These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. ARISTOTLE expands the list of novel anticoagulants for thromboprophylaxis in atrial fibrillation. Tzeis S; Andrikopoulos G Angiology; 2012 Oct; 63(7):558-9. PubMed ID: 22669951 [No Abstract] [Full Text] [Related]
5. Apixaban (eliquis) for stroke prevention in atrial fibrillation. Beck RA; King WM Am Fam Physician; 2014 Apr; 89(8):672-5. PubMed ID: 24784127 [No Abstract] [Full Text] [Related]
7. Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation? Strain J; Templeton K S D Med; 2013 Jan; 66(1):20-1. PubMed ID: 23342716 [No Abstract] [Full Text] [Related]
8. [Prevention of stroke in nonvalvular atrial fibrillation. Oral direct factor Xa inhibitor apixaban: positive experiences in general medical practice]. MMW Fortschr Med; 2013 Sep; 155(16):62-3. PubMed ID: 24279159 [No Abstract] [Full Text] [Related]
9. [Prophylaxis of thromboembolism in atrial fibrillation: new oral anticoagulants and left atrial appendage closure]. Zeus T; Kelm M; Bode C Dtsch Med Wochenschr; 2015 Aug; 140(16):1213-5. PubMed ID: 26261929 [TBL] [Abstract][Full Text] [Related]
10. [Atrial fibrillation: what the GP needs to know]. Diener HC; Kaeufer T; Bode C MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796 [No Abstract] [Full Text] [Related]
11. Apixaban versus warfarin in atrial fibrillation. Simini B N Engl J Med; 2012 Jan; 366(1):88-9; author reply 89-90. PubMed ID: 22216850 [No Abstract] [Full Text] [Related]
12. [The new anticoagulants - their role in secondary prevention of thromboembolism after stroke]. Seiffge D; Nedeltchev K; Lyrer P Ther Umsch; 2012 Sep; 69(9):517-22. PubMed ID: 22923355 [TBL] [Abstract][Full Text] [Related]
13. [New oral anticoagulants are as safe in elderly patients as conventional drugs]. Steurer J Praxis (Bern 1994); 2014 Aug; 103(17):1032. PubMed ID: 25146949 [No Abstract] [Full Text] [Related]
14. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
15. [Current and future therapies for prophylaxis of thromboembolism in atrial fibrillation]. Geisler T; Gawaz M MMW Fortschr Med; 2011 Apr; 153(15):27-30; quiz 31. PubMed ID: 21667556 [No Abstract] [Full Text] [Related]
16. A new era for anticoagulation in atrial fibrillation. Mega JL N Engl J Med; 2011 Sep; 365(11):1052-4. PubMed ID: 21870977 [No Abstract] [Full Text] [Related]
17. Apixaban (Eliquis)--a new oral anticoagulant for atrial fibrillation. Med Lett Drugs Ther; 2013 Feb; 55(1409):9-10. PubMed ID: 23381226 [No Abstract] [Full Text] [Related]
18. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation. Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261 [TBL] [Abstract][Full Text] [Related]
19. [The ARISTOTLE study]. Di Pasquale G; De Caterina R G Ital Cardiol (Rome); 2012 Sep; 13(9):557-62. PubMed ID: 22825340 [No Abstract] [Full Text] [Related]
20. Apixaban for the prevention of stroke in atrial fibrillation. Littrell R; Flaker G Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):143-9. PubMed ID: 22292869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]